{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:32:15Z","timestamp":1792614735494,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1249\/mss.0b013e3182843961","type":"journal-article","created":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T12:27:41Z","timestamp":1359721661000},"page":"1043-1050","source":"Crossref","is-referenced-by-count":23,"title":["Intensive Lifestyle Modification Reduces Lp-PLA2 in Dyslipidemic HIV\/HAART Patients"],"prefix":"10.1249","volume":"45","author":[{"given":"JOSHUA S.","family":"WOOTEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PREETHI","family":"NAMBI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BAIBA K.","family":"GILLARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HENRY J.","family":"POWNALL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IVONNE","family":"CORAZA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LYNNE W.","family":"SCOTT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VIJAY","family":"NAMBI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHRISTIE M.","family":"BALLANTYNE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ASHOK","family":"BALASUBRAMANYAM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"4","key":"R1-4-20210211","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1177\/039463201102400401","article-title":"Atherosclerosis: a classic inflammatory disease.","volume":"24","author":"Anogeianaki","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"7","key":"R3-4-20210211","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1210\/jc.2010-3067","article-title":"Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of heart positive, a randomized, controlled trial.","volume":"96","author":"Balasubramanyam","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"25","key":"R4-4-20210211","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1161\/hc5001.100624","article-title":"Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.","volume":"104","author":"Ballantyne","year":"2001","journal-title":"Circulation"},{"issue":"10","key":"R6-4-20210211","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ncpcardio0321","article-title":"Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke.","volume":"2","author":"Caslake","year":"2005","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"20","key":"R7-4-20210211","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/jama.1986.03380200073024","article-title":"Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.","volume":"256","author":"Castelli","year":"1986","journal-title":"JAMA"},{"issue":"4","key":"R8-4-20210211","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/01.ATV.0000258789.21585.76","article-title":"Low plasma RANTES levels are an independent predictor of cardiac mortality in patients referred for coronary angiography.","volume":"27","author":"Cavusoglu","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"R9-4-20210211","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/378131","article-title":"Adult ACTGCS, and America HIVMAotIDSo. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.","volume":"37","author":"Dube","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R10-4-20210211","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1749-6632.2001.tb03913.x","article-title":"Cardiovascular disease risk factors in HIV-infected patients in the HAART era.","volume":"946","author":"Galli","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"R11-4-20210211","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13105-010-0052-4","article-title":"A single session of intense exercise improves the inflammatory response in healthy sedentary women.","volume":"67","author":"Garcia","year":"2011","journal-title":"J Physiol Biochem"},{"issue":"2","key":"R12-4-20210211","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1194\/jlr.M600249-JLR200","article-title":"Dynamics of dense electronegative low density lipoproteins and their preferential association with lipoprotein phospholipase A(2).","volume":"48","author":"Gaubatz","year":"2007","journal-title":"J Lipid Res"},{"issue":"9","key":"R13-4-20210211","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1043-2760(01)00472-6","article-title":"Insulin resistance in the HIV-lipodystrophy syndrome.","volume":"12","author":"Grinspoon","year":"2001","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"R14-4-20210211","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2796.2010.02258.x","article-title":"Lipoprotein-associated phospholipase A(2) activity and mass in relation to vascular disease and nonvascular mortality.","volume":"268","author":"Group","year":"2010","journal-title":"J Intern Med"},{"issue":"12","key":"R15-4-20210211","doi-asserted-by":"crossref","first-page":"e25734","DOI":"10.1371\/journal.pone.0025734","article-title":"RANTESCCL5 and risk for coronary events: results from the MONICAKORA Augsburg case-cohort, Athero-Express and CARDIoGRAM studies.","volume":"6","author":"Herder","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"R16-4-20210211","first-page":"277","article-title":"Prescribing of contraindicated protease inhibitor and statin combinations among HIV-infected persons.","volume":"38","author":"Hulgan","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"R17-4-20210211","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/hh1601.095598","article-title":"Phospholipase A(2) in vascular disease.","volume":"89","author":"Hurt-Camejo","year":"2001","journal-title":"Circ Res"},{"issue":"4","key":"R18-4-20210211","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00041433-200108000-00009","article-title":"Diabetes and other coronary heart disease risk equivalents.","volume":"12","author":"James","year":"2001","journal-title":"Curr Opin Lipidol"},{"issue":"7","key":"R19-4-20210211","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1476-5381.2010.01147.x","article-title":"Chemokine receptor CCR5: from AIDS to atherosclerosis.","volume":"162","author":"Jones","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"15","key":"R20-4-20210211","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/00002030-200110190-00021","article-title":"Short-term exercise training improves body composition and hyperlipidaemia in HIV-positive individuals with lipodystrophy.","volume":"15","author":"Jones","year":"2001","journal-title":"AIDS"},{"issue":"12","key":"R21-4-20210211","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0026-0495(99)90240-8","article-title":"Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.","volume":"48","author":"Khovidhunkit","year":"1999","journal-title":"Metabolism"},{"issue":"6","key":"R22-4-20210211","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.amjcard.2006.04.011","article-title":"Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with coronary artery disease.","volume":"98","author":"Kuvin","year":"2006","journal-title":"Am J Cardiol"},{"issue":"3","key":"R23-4-20210211","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1520-037X.2006.05547.x","article-title":"Lipoprotein-associated phospholipase A2: review and recommendation of a clinical cut point for adults.","volume":"9","author":"Lanman","year":"2006","journal-title":"Prev Cardiol"},{"issue":"11","key":"R24-4-20210211","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jacc.2011.11.038","article-title":"Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected individuals: a randomized trial.","volume":"59","author":"Lazzaretti","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"R25-4-20210211","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.intimp.2006.01.002","article-title":"IL-2 increased RANTES production and CD25 expression in cultured PBMCs only from antiretroviral treated HIV-1 patients with detectable viral loads.","volume":"6","author":"Lozano","year":"2006","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"R26-4-20210211","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.mol.0000174155.61307.5f","article-title":"Lipoprotein-associated phospholipase A2 as a target of therapy.","volume":"16","author":"Macphee","year":"2005","journal-title":"Curr Opin Lipidol"},{"issue":"3","key":"R27-4-20210211","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00041433-200106000-00011","article-title":"Antiretroviral therapy-associated hyperlipidaemia in HIV disease.","volume":"12","author":"Mooser","year":"2001","journal-title":"Curr Opin Lipidol"},{"issue":"3","key":"R28-4-20210211","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1055\/s-0037-1613381","article-title":"Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome.","volume":"89","author":"Nomura","year":"2003","journal-title":"Thromb Haemost"},{"issue":"3","key":"R29-4-20210211","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/313995","article-title":"Coronary artery disease and human immunodeficiency virus infection.","volume":"31","author":"Passalaris","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"28","key":"R30-4-20210211","doi-asserted-by":"crossref","first-page":"17660","DOI":"10.1074\/jbc.273.28.17660","article-title":"Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis.","volume":"273","author":"Perry","year":"1998","journal-title":"J Biol Chem"},{"issue":"4","key":"R31-4-20210211","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00002030-199903110-00002","article-title":"Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection.","volume":"13","author":"Polo","year":"1999","journal-title":"AIDS"},{"issue":"6","key":"R33-4-20210211","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ajcn\/81.6.1405","article-title":"Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriacylglycerolemia in HIV lipodystrophy syndrome.","volume":"81","author":"Sekhar","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"R34-4-20210211","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bbalip.2009.02.015","article-title":"The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.","volume":"1791","author":"Tellis","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"R35-4-20210211","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1249\/01.mss.0000191347.73848.80","article-title":"Exercise training in HIV-1-infected individuals with dyslipidemia and lipodystrophy.","volume":"38","author":"Terry","year":"2006","journal-title":"Med Sci Sports Exerc"},{"issue":"9725","key":"R36-4-20210211","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","article-title":"Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.","volume":"375","author":"Thompson","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"R38-4-20210211","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/eurheartj\/ehq367","article-title":"Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study.","volume":"32","author":"Virani","year":"2011","journal-title":"Eur Heart J"},{"issue":"5","key":"R39-4-20210211","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MOL.0b013e3283307c16","article-title":"Lipoprotein-associated phospholipase A(2) and atherosclerosis.","volume":"20","author":"Wilensky","year":"2009","journal-title":"Curr Opin Lipidol"},{"issue":"6","key":"R40-4-20210211","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11883-011-0201-4","article-title":"Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).","volume":"13","author":"Wong","year":"2011","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"R41-4-20210211","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.lab.2004.01.012","article-title":"Lack of good correlation of serum CC-chemokine levels with human immunodeficiency virus-1 disease stage and response to treatment.","volume":"143","author":"Ye","year":"2004","journal-title":"J Lab Clin Med"}],"container-title":["Medicine & Science in Sports & Exercise"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005768-201306000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:23:41Z","timestamp":1787322221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005768-201306000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1249\/mss.0b013e3182843961","relation":{},"ISSN":["0195-9131"],"issn-type":[{"value":"0195-9131","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}